Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Main Authors: Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson
Format: Artigo
Sprog:engelsk
Udgivet: 2019
Online adgang:https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Internet

https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf

Lignende værker